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Abstract
Cerebral blood flow autoregulation (CA) shifts to higher blood pressures in chronic hyper-
tensive patients, which increases their risk for brain damage. Although cerebral vascular
smooth muscle cells express the potent vasodilatatory peptides calcitonin gene-related
peptide (CGRP) and adrenomedullin (AM) and their receptors (calcitonin receptor-like re-
ceptor (Calclr), receptor-modifying proteins (RAMP) 1 and 2), their contribution to CA during
chronic hypertension is poorly understood. Here we report that chronic (10 weeks) hyper-
tensive (one-kidney-one-clip-method) mice overexpressing the Calclr in smooth muscle
cells (CLR-tg), which increases the natural sensitivity of the brain vasculature to CGRP and
AM show significantly better blood pressure drop-induced cerebrovascular reactivity than
wt controls. Compared to shammice, this was paralleled by increased cerebral CGRP-bind-
ing sites (receptor autoradiography), significantly in CLR-tg but not wt mice. AM-binding
sites remained unchanged. Whereas hypertension did not alter RAMP-1 expression (drop-
let digital (dd) PCR) in either mouse line, RAMP-2 expression dropped significantly in both
mouse lines by about 65%. Moreover, in wt only Calclr expression was reduced by about
70% parallel to an increase of smooth muscle actin (Acta2) expression. Thus, chronic hy-
pertension induces a stoichiometric shift between CGRP and AM receptors in favor of the
CGRP receptor. However, the parallel reduction of Calclr expression observed in wt mice
but not CLR-tg mice appears to be a key mechanism in chronic hypertension impairing
cerebrovascular reactivity.
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Introduction
In healthy subjects cerebral blood flow autoregulation (CA) ensures a relatively constant cere-
bral blood flow (CBF) during variations in arterial blood pressure between 50–150 mmHg.
Consequently, impairment of CA allows CBF to either drop or rise passively during fluctua-
tions of arterial blood pressure, which can result, next to syncope and falls, in severe cerebral is-
chemia or brain edema [1]. The clinical relevance of disturbed CA becomes obvious
considering the fact that the major health problem in Western countries, hypertension, is asso-
ciated with an impairment of the dynamic CA [2]. In patients suffering from chronic hyperten-
sion the lower limit of CA shifts towards higher pressures thereby making these individuals
highly vulnerable to brain ischemia in response to anti-hypertensive therapy or when subjected
to acute hypotension of other reasons [3]. For obvious reasons, the upper limit of CA has not
been determined in normo- or hypertensive humans. In normotensive baboons, however, it is
located between 120 and 150 mm Hg and between 155 and 170 mm Hg in chronic hyperten-
sive baboons [4]. Although the alterations of CA in response to chronic hypertension have
been described many years ago [5,6,7] the mechanisms behind remain poorly understood.
We hypothesize that expression changes of the receptors for calcitonin gene-related peptide
(CGRP) and/or adrenomedullin (AM) play a significant role in the patho-physiology of CA
during chronic hypertension because both peptides are the most potent vasodilatatory peptides
known so far [8,9] and previous data suggest their involvement in CA [10,11,12]. The receptors
for these peptides are heterodimers of the calcitonin receptor-like receptor (Calclr) and either
the receptor-activity modifying protein (RAMP)-1 or -2 forming at the cell surface a receptor
for CGRP or AM, respectively [13]. Of note, the Calclr might be constitutively expressed
whereas the ligand specificity as well as the sensitivity of the cells might be under regulation by
exchanging the associated RAMP [14]. All receptor components for AM as well as CGRP are
naturally expressed in vascular smooth muscle cells [15] and vasodilatation of rat pial arteries
in response to a stepwise hypotension is mediated, at least in part, by CGRP, which is released
from perivascular sensory fibers. Accordingly, vasodilatation in response to hypotension is at-
tenuated by CGRP receptor desensitization and after application of capsaicin, which results in
depletion of CGRP from perivascular neurons [16,17]. On the other hand, AM levels are about
50% higher in the cerebral than in the peripheral circulation because cerebral endothelial cells
secrete large amounts of AM [11]. Acutely administered AM is able to increase CBF in a dose
dependent manner as measured in rats in superficial cortical layers with Laser-Doppler flow-
metry [18].
Our data obtained in the present study suggest that increased Calclr signaling preserves ce-
rebrovascular reactivity during chronic hypertension. RAMP-2 but not RAMP-1 expression is
highly suppressed suggesting that in chronic hypertension, first, the receptor stoichiometry for
CGRP and AM is shifted by expression changes of the RAMPs and, second, that compensatory
mechanisms to maintain cerebrovascular reactivity during chronic hypertension rest rather on
CGRP than on AM signaling. Moreover, in chronic hypertensive wt mice Calclr expression is
also suppressed, which could be a so far underrated factor contributing to the reduced cerebro-
vascular reactivity in hypertensive patients.
Methods
Animals
Mice transgenic for the calcitonin receptor-like receptor (CLR-tg) overexpress a V5
(GKPIPNPLLGDST) tagged rat CLR under control of the mouse smooth-muscle α-actin pro-
moter (Acta2) [19,20]. Non-transgenic littermates (BL6xDBA2) of CLR-tg mice served as wild
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type controls. The experiments in this study conformed to the 'European Convention for the
Protection of Vertebrate Animals used for Experimental and other Scientific Purposes' (Coun-
cil of Europe No 123, Strasbourg 1985) as well as institutional and local governmental guide-
lines and were approved by the Cantonal Veterinary Department, Zurich, Switzerland (Permit
Number: 57/2008).
Surgery
Chronic hypertension was induced in female mice using the one-kidney-one-clip (1K1C)
model [21]. Briefly, mice aging 7 months were anesthetized with 4% Isoflurane in O2. Then the
right renal artery was clipped with an U-shaped stainless steel surgical clamp (2 x 1 x 0.8 mm
outer dimensions with a gap width of 0.12 mm and gap length of 1.5 mm, Exidel SA R&Dmi-
crotechniques). In sham-operated animals no clip was placed. One week later the left kidney
was removed under 4% Isoflurane anesthesia in O2. Before wound closure always 50000 U Ben-
zypenicillin-Na/K (Penicillin 10 Mega, Grünenthal) dissolved in 0.9% saline were dropped into
the wound. Prior to discontinuation of the anesthesia and twice a day for three subsequent
days the mice were treated with 5mg/kg Flunixin s.c.. Initially we tested the effect of this sur-
gery on mean arterial blood pressure 6, 8 and 10 weeks after the second operation. A significant
increase of blood pressure was established 8 weeks after surgery and stayed constant thereafter
(not shown). All subsequent experiments were therefore performed 10 weeks after surgery.
For measuring cerebral autoregulation (CA) [22] anesthesia was induced with 4% Isoflurane
in O2. Then the mice were equipped with catheters in both femoral arteries and one femoral
vein for the measurement of blood pressure, heart rate (PlugSys, Hugo Sachs Electronics, and
PowerLab, ADInstruments), blood gases and acid base status (AVL700, Radiometer Medical),
infusion of anesthetics (see below) and exsanguination. Before closing the wounds a drop of
2% Lidocain (Streuli) was applied to the wound. Thereafter the mice were placed in a stereotac-
tic frame, the scull was exposed and flushed with 2% Lidocain. Then a Laser speckle perfusion
imager (moorFLPI, Moor Instruments) was adjusted to its maximal magnification and five re-
gions of interest (ROI’s, 3 on the left and 2 on the right parietal cortex) were defined avoiding
visible vessels. In accordance with others [23] we found that the transparency of the scull of
mice is high enough to not reduce significantly the laser signal as long as it is kept wet with arti-
ficial cerebrospinal fluid or 0.9% saline warmed to 37°C. The images were acquired at 25 Hz
and the traces of the ROI’s were sampled with a time constant of 0.5 sec. For measurement of
CA the anesthesia was changed to intravenous Etomidate (Etomidat Lipuro) at an infusion rate
of 14–26μg/min as described [22]. The CA measurements that were commenced 20 min after
changing the anesthesia and measurement of the arterial acid-base-status (ABL700, Radiome-
ter Medical). During surgery and the subsequent measurements of static CA animals were al-
lowed to breath spontaneously pure oxygen.
Measurement of cerebral autoregulation CA [22]
At the very beginning of the recordings a screwdriver handle was dropped onto the arterial line
connected to the blood pressure transducer. This produced an artifact simultaneously in both
the blood pressure and the laser perfusion trace that was later used to synchronize both traces
for offline calculation of the CA limits. Then the mice were slowly exsanguined via the second
arterial line while continuously recording the laser speckle perfusion and blood pressure signal.
The exsanguination rate was adjusted manually by continuous inspection of the blood pressure
trace to get a linear and constant decrease of the blood pressure (about 1–2mmHg/min, total
exsanguination time: 35–40min).
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For determination of the CA limits all laser speckle perfusion and blood pressure values be-
fore the marker artifact were discarded and then the data were averaged in ten second intervals
using macros written in Excel (Microsoft). The laser speckle perfusion values obtained in this
way were plotted as a function of the corresponding blood pressure values. Then the lower CA
limit was determined by linear extrapolation by starting with the lowest blood pressure values
and the upper limit in a similar way by starting with the highest blood pressure values as de-
scribed elsewhere for the “plateau constraint” [24]. This was done separately for each of the
five ROI’s. The final CA limits for each animal were defined as the mean of those determined
for each ROI and these mean values were used for statistical analysis. The intra-individual vari-
ation of the ROI’s was very low (coefficient of variation: 1.3–2.8%).
In addition to determination of the classical CA limits we intended to better characterize the
cerebrovascular reactivity by introducing a new way of analyzing the perfusion data obtained.
To this end, for each time point from the moment on of starting the exsanguination the perfu-
sion per mmHg was calculated, which we define as pressure drop-induced vasodilatation
(PDiVD). This parameter is explained in Fig 1 and its legend.
Fig 1. Definition of pressure drop-induced vasodilatation (PDiVD). The upper panel shows normal CA curves (solid lines) with typical “knee”-shaped
deviating from a linear correlation between blood pressure and perfusion that indicates completely lost CA (dashed line) [22]. The corresponding CA limits
are indicated. The vertical gray shaded area demonstrates that the lower CA limit could stay at the same blood pressure value even when the CA curve
would be flatter, meaning that the same lower CA limit would be associated with less perfusion. To quantify this, we plotted the time course of the perfusion
per blood pressure of the CAmeasurement (lower panels). When CA is abrogated (dashed line in the upper panel) the perfusion/blood pressure passively
decreases with time or falling systemic blood pressure (lower right panel), which is typical for elastic tubes. In contrast, with intact CA (solid lines in the upper
panel) the perfusion/blood pressure starts to rise from a certain time point on, reaches a maximum and then falls again (lower left panel). We defined the
difference between the initial perfusion/blood pressure value and the maximal one as PDiVD (horizontal dashed lines in the lower left panel).
doi:10.1371/journal.pone.0123697.g001
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After completion of the CA measurements the brain was removed and cut sagittally into
two halves of which one was used for receptor autoradiography and the other for gene
expression analysis.
Receptor autoradiography for αCGRP and AM
αCGRP and AM binding sites in the brain were determined by receptor autoradiography using
either 125I labeled αCGRP or AM (PerkinElmer) as described [25]. Briefly, 20μm thick cryosec-
tions were incubated for 3h at 4°C in a blocking solution containing 50mM Tris-HCl and 3%
BSA, pH 7,4. Then this buffer was exchanged with the same buffer but now containing the ra-
dioactively labeled peptides (60 nCi / slide) and incubated overnight at 4°C. After washing
away the buffer with distilled water the slides were air died and exposed to an X-ray film for
two weeks. Unspecific binding was assessed by adding 1μM unlabelled αCGRP or AM, respec-
tively, to the pre-incubation blocking solution.
Then, images of the X-ray films were acquired using a densitometry camera (CoolSNAP cf,
Roper Scientific (Photometrics)) together with an ultra stable precision illuminator (Model
R95 Northern light, Imaging Research). The resulting optical densities were quantified using
an image analyzing system (MCID Analysis 7.0) after calibration with the gray values of 14C
standards co-exposed on the same X-ray film. Beforehand, these 14C standards had been cali-
brated to assign each optical density a tissue concentration of 125I (nC/g).
Gene expression analysis
RNA extracts (RNeasy, Qiagen) obtained after on-membrane DNase I digestion (Qiagen) of
brain hemispheres were assessed for their quality by measuring the 280/260nm ratio and using
the Agilent bioanalyzer (Agilent Technologies). Only samples with an A260/A280 ratio>
1.95 were accepted and RNA integrity number (IN) determined. These samples had an IN of
7.9 ±0.6 and were transcribed to cDNA (iScript, Bio-Rad). Always exactly 250ng RNA were
transcribed and the resulting product was then diluted 1:100. Of this solution 9μl were taken
with a high-precision pipette (Rainin) for quantification of target gene expression (cf. Table 1)
using droplet digital PCR (ddPCR, Bio-Rad) according to the manufactures instruction. To
this end, end-point PCR with 41 cycles was performed after splitting each sample into about
20000 droplets. Next the droplet reader (QX100, Bio-Rad) used at least 10000 droplets to deter-
mine the percentage of positive droplets and calculation of copy number per μl.
As negative control transcription reactions of isolated RNA were also performed without re-
verse transcriptase. In addition, each primer / probe pair was tested on genomic mouse DNA
Table 1. TaqMan Gene Expression Assays used for ddPCR.
Gene name Gene
Symbol
Reference sequence Assay
location
Applied Biosystems
reference
Label
calcitonin receptor-like
receptor
Calcrl http://www.ncbi.nlm.nih.gov/nuccore/NM_018782.2 1140 Mm00516986_m1 VIC
Receptor activity
modifying protein 1
(variants 1–3)
RAMP-1 http://www.ncbi.nlm.nih.gov/nuccore/NM_016894.3, http://www.
ncbi.nlm.nih.gov/nuccore/NM_178401.3, http://www.ncbi.nlm.
nih.gov/nuccore/NM_001168392.1
321 Mm00489796_m1 FAM
Receptor activity
modifying protein 2
RAMP-2 http://www.ncbi.nlm.nih.gov/nuccore/NM_019444.2 332 Mm00490256_g1 FAM
actin, alpha 2, smooth
muscle
Acta2 http://www.ncbi.nlm.nih.gov/nuccore/NM_007392.3 1403 Mm00725412_s1 FAM
actin, beta Actb http://www.ncbi.nlm.nih.gov/nuccore/NM_007393.3 1230 Mm00607939_s1 VIC
doi:10.1371/journal.pone.0123697.t001
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and under these conditions none of them showed positive droplets. All expression analyses
were performed in duplicate using mouse “best coverage” TaqMan kits from Applied Biosys-
tems (cf. Table 1). The reproducibility of the measurement of copy numbers per μl was quite
good (average coefficient of variation 12 ±8.8%).
Statistics
Data were analyzed with the GraphPad PRISM 4 Software (version 4.01) using ANOVA and
Students t-test or Kruskal-Wallis test (in case the number of values were not equal for all
groups) for unpaired samples with Bonferroni’s or Dunn’s post hoc test respectively. P values
of<0.05 were considered significant.
Results
Table 2 shows the physiological variables measured just before commencing the determination
of cerebrovascular reactivity. There were no differences between wt and CLR-tg. Mean arterial
blood pressure and heart rate in sham animals were also not different between the genotypes
and comparable to the values reported previously in untreated wt or CLR-tg mice [20].
The effect of the 1K1C surgery on mean arterial blood pressure was tested 6, 8 and 10 weeks
later. A significant increase of the mean arterial blood pressure of about 30 mmHg in both lines
was established 8 weeks after surgery and stayed constant thereafter. These mice were also sub-
jected to measurement of the lower CA limit using the “plateau constraint” approach [24]. Sim-
ilar to mean arterial blood pressure the lower CA limit was significantly increased by about
8–10 mmHg after 8 weeks of hypertension without further increase until the 10th week (Fig 2).
All subsequent experiments were therefore performed 10 weeks after surgery.
Fig 3 shows the cerebrovascular reactivity after 10 weeks of hypertension. The final elevation
in systemic mean arterial blood pressure (MABP) varied between 106 and 158 mmHg and was
the same in wt and CLR-tg mice (Fig 2A, left bar graph). However when omitting animals with
a MABP below 115 mmHg, which can be considered as pre-hypertensive according to the clas-
sification of the American Heart Association (AHA) given for humans [http://www.heart.org/
HEARTORG/Conditions/HighBloodPressure/AboutHighBloodPressure/Understanding-
Blood-Pressure-Readings_UCM_301764_Article.jsp] the CLR-tg mice showed a slightly but
significantly lower MABP (Fig 2A, left bar graph) suggesting that hypertension in wt mice was
marginally more severe. When comparing the shift in the lower limit of CA between wt and
CLR-tg mice there was no difference independent of taking all animals into account or only
those with a MABP above 115mmHg. In contrast, CLR-tg showed consistently higher PDiVD
suggesting better cerebrovascular reactivity. Moreover these data also suggest that PDiVD ap-
pears to be a better parameter to detect differences in cerebrovascular reactivity compared to a
shift of the lower CA limit.
Receptor autoradiography showed no significant effect of either genotype or hypertension
regarding AM binding (mean of all investigated brain structures: wtnormorensive: 160.2 ±48.3
nCi/g, CLR-tgnormotensive: 178.1 ±27.5 nCi/g, wthypertensive: 148.4 ±27.3 nCi/g, CLR-tghypertensive:
Table 2. Physiological variables.
pH pCO2 (mmHg) pO2 (mmHg) BE (mmol/L) Hct (%)
wt (n = 19) 7.32 ±0.07 35.8 ±4.7 433.7 ±110 -11.9 ±2.1 43.4 ±4
CLR-tg (n = 17) 7.32 ±0.11 34.1 ±12.5 424.4 ±88 -11.1 ±1.7 43 ±3.7
Values are means ±SD, wt = control mice, CLR-tg = calcitonin receptor-like receptor transgenic mice (BE = base excess, Hct = hematocrit).
doi:10.1371/journal.pone.0123697.t002
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161.6 ±33.3 nCi/g). In contrast, brain sections from CLR-tg mice showed considerably
more CGRP binding (Fig 4). Compared to wt mice, after sham-operation as well as after
1K1C surgery CLR-tg mice showed 59% and 73% higher CGRP binding, respectively. 1K1C
surgery-induced hypertension increased CGRP binding in wt as well as in CLR-tg mice
(mean of all investigated brain structures shown in Fig 4: wtnormorensive: 158.2 ±55.7 nCi/g,
CLR-tgnormotensive: 251.1 ±43.3 nCi/g, wthypertensive: 225.9 ±48.1 nCi/g, CLR-tghypertensive:
390.6 ±59.9 nCi/g). However, in wt mice this was significant just in 1 out of 23 brain structures
suggesting a slight up-regulation of functional CGRP-receptors. In contrast, in chronic hyper-
tensive CLR-tg mice 8 brain structures showed significant more CGRP binding compared to
normotensive CLR-tg mice.
Expression analysis (cf. Table 1) of the CGRP and AM receptor components as well as the
contractile proteins of the smooth muscle in the brain (Fig 5) revealed in normotensive mice,
as expected, considerably higher Calclr expression in CLR-tg mice. Chronic hypertension in-
duced in wt mice a significant suppression of Calclr mRNA (-70%) whereas it was slightly but
non-significantly increased in hypertensive CLR-tg mice compared to their normotensive con-
trols. This latter finding could be due to the hypertension-induced increase of the expression of
Acta2 (significant in wt mice but not in CLR-tg mice) because the Acta2 promoter drives the
transgenic overexpression of the Calclr in the CLR-tg mice. Generally, RAMP-1 expression was
up to 10-times higher than RAMP-2 expression. During chronic hypertension RAMP-1 ex-
pression was slightly but non-significantly reduced (-28%) in both mouse lines. In contrast,
compared to normotensive mice, RAMP-2 expression was clearly and significantly lower in hy-
pertensive wt (-61%) as well as hypertensive CLR-tg mice (-66%). Regarding contractile protein
expression in the brain extracts there was a considerable increase in smooth muscle alpha actin
(Acta2) expression with chronic hypertension in line with others [26] of about 380% in wt and
about 170% (non-significant) in CLR-tg mice. As another important contractile protein in
Fig 2. Time course of the upwards sift of the lower CA limit after 1K1C surgery. The lower CA limit shifted in both mouse lines in a similar fashion.
Significantly elevated lower CA limits were not observed before 8 weeks of hypertension. Thereafter no further shift of the lower CA limit occurred. * = p<0.05
after pooling the data from 0 and 6 weeks and 8 and 10 weeks respectively. Means ±SD of as many animals as indicated.
doi:10.1371/journal.pone.0123697.g002
Calclr Signaling and Cerebral Autoregulation
PLOS ONE | DOI:10.1371/journal.pone.0123697 April 10, 2015 7 / 15
smooth muscle we also determined β-actin (Actb) expression that was however not influenced
by either genotype or hypertension.
Fig 3. Assessment of cerebrovascular reactivity. Ten weeks after 1K1C surgery the systemic mean arterial blood pressure (MABP) of all animals ranged
from 106 to 158 mmHg and did not differ between wt and CLR-tg mice (A, left bar graph). The lower CA limit was comparably shifted in both mouse lines (A,
middle bar graph; cf. also Fig 2). However the PDiVD was significantly higher in CLR-tg compared to wt mice (A, right bar graph). When excluding two wt and
two CLR-tg mice with a MABP below 115 mmHg, the CLR-tg showed slightly but significantly lower MABP (B, left bar graph), again no difference in the lower
CA limit (B, middle bar graph) and an even more pronounced higher PDiVD (B, right bar graph). Means ±SD of as many animals as indicated.
doi:10.1371/journal.pone.0123697.g003
Calclr Signaling and Cerebral Autoregulation
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Fig 4. CGRP binding sites in different brain structures.Generally CGRP binding was much higher in CLR-tg mice. Moreover, in wt mice hypertension did
increase CGRP binding non-significantly only by trend whereas in CLR-tg mice hypertension-induced increase in CGRP binding was more pronounced and
significant (* = p<0.05 and ** = p<0.01 vs. normotensive wt mice, # = p<0.05 and ## = p<0.01 vs. normotension, + = p<0.05 and ++ = p<0.01 vs.
hypertensive wt mice). Means ±SD of 7 animals per group.
doi:10.1371/journal.pone.0123697.g004
Calclr Signaling and Cerebral Autoregulation
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Fig 5. Gene expression analysis of brain tissue. The abundance of Calclr mRNAwas due to the transgenic overexpression much higher in the CLR-tg
mice (upper left panel). Hypertension induced a significant reduction of the Calclr expression by about 70% in wt mice whereas it slightly but non-significantly
increased in CLR-tg mice most likely due to the increased expression of Acta2 (upper right panel) as the transgene of the CLR-tg mice is driven by the Acta2
promoter. Expression of the RAMP-1 mRNA was the same in both mouse lines with a non-significant tendency for reduction in response to hypertension. In
contrast RAMP-2 expression was not only generally much less abundant but also significantly reduced by about 65% in both mouse lines in response to
hypertension. Actb showed no expression changes in response to genetic alteration or chronic hypertension. Means ±SEM of 7 animals per group.
doi:10.1371/journal.pone.0123697.g005
Calclr Signaling and Cerebral Autoregulation
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Discussion
Here we show that during chronic hypertension increased Calclr-signaling via CGRP receptors
can maintain cerebrovascular reactivity despite an upward shift in the lower CA limit and the
previously observed hypertension-induced increased smooth muscle alpha actin expression
[26].
For humans it is known that women have lower systolic blood pressure levels than men es-
pecially during early adulthood [27,28]. In normal mice gender-dependent blood pressure dif-
ferences appear to be quite strain dependent with higher systolic blood pressure observed
sometimes in males but also in females [29]. In the present study we used mice with a
C57BL6xDBA2 background and C57BL6 as well as DBA2 mice females have in tendency
higher systolic blood pressure values than males [29].
Per definition essential (or primary) hypertension develops spontaneously without identi-
fied medical cause although there is a clear correlation with obesity and alcohol or tobacco con-
sumption [30]. This form of hypertension accounts for 90–95% of all cases. Enormous
progress has been achieved in the treatment of chronic essential hypertension but the clinical
problems arising from the shift in cerebral blood flow auto-regulation towards higher blood
pressure are not solved satisfactorily. For example, the advances of surgery and anesthesia
allow operating on patients at much higher age and much lower general condition than in the
past decades. However, this increases the risk and thus incidence of severe blood pressure dis-
turbances during surgery and as a consequence brain damage because in chronic hypertensive
patients CA, the important physiological mechanism that keeps CBF relatively constant in face
of blood pressure changes, is shifted towards higher blood pressure values [5,7].
In our experiments 1K1C surgery induced an upward shift of the lower CA limit to the
same extend in wt as well as CLR-tg mice. At the first glance this might suggest that enhancing
the natural Calclr-expression of vascular smooth muscle cells [15] as in our CLR-tg mice
[19,20] does not affect cerebrovascular reactivity during chronic hypertension. However, when
determining the PDiVD (cf. Fig 1), there was a clear and significant effect of Calclr overexpres-
sion, namely that this genetic alteration is associated with a superior cerebrovascular reactivity
(cf. Fig 3). Of note, this observation also suggests that merely determining the lower CA limit is
not sufficient to judge cerebrovascular reactivity.
The molecular mechanisms of the RAMP expression and regulation are not entirely under-
stood although the RAMP-1 gene expression might be mediated by a negatively acting tran-
scription factor that represses RAMP-1 gene expression in RAMP-1 negative tissues [31].
Regarding the present study it is important to note that RAMP-2 expression is rapidly changed
even upon small changes in systemic blood pressure. Decreases and increases of ±20–30
mmHg result in increases and decreases of RAMP-2 mRNA levels, respectively, in numerous
brain structures whereas Claclr mRNA levels were not altered [32]. This suggests that the vaso-
dilator responsiveness in hypertension at least to AM is regulated predominatly via the expres-
sion level of RAMPs and not the Calclr. Overexpression of the Calclr in smooth muscle cells
should therefore capture newly produced RAMPs, form more surface receptors for CGRP and
/ or AM and, thus, increase the sensitivity of the vasculature to the respective peptide. To test
this hypothesis we overexpressed in mice the Calclr in smooth muscle containing tissue, in-
cluding the cerebral vasculature.
As the Calclr can associate with different RAMPs resulting in receptors for either CGRP or
AM we wanted to assess which of these peptide is responsible for the better cerebrovascular re-
activity in our CLR-tg mice. Unfortunately, the performance of commercially available anti-
bodies for detection of CGRP and AM receptor components are in general raised against the
human proteins and had poor performance on mouse brain sections. Therefore we used
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quantitative receptor autoradiography that in contrast to antibodies detects functional receptor
complexes in order to compare the expression changes in CGRP and AM receptors in response
to chronic hypertension. AM-receptor binding was not different between naive wt and CLR-tg
but in both lines marginally although non-significantly reduced in response to chronic hyper-
tension. In contrast, CLR-tg mice generally showed higher CGRP binding than wt mice and
after induction of chronic hypertension we found a clear increase in CGRP-receptor binding in
CLR-tg mice but only a trend in wt mice. Of note the striking down regulation of RAMP2 in
parallel with unchanged RAMP1 expression suggests that CGRP receptors rather than AM re-
ceptors maintain cerebrovascular reactivity during chronic hypertension. Accordingly, autore-
gulatory vasodilatation in response to hypotension is attenuated by CGRP receptor
desensitization and after application of capsaicin, which results in depletion of CGRP from
perivascular neurons [10]. All these findings and also those of others suggest that, compared to
AM, CGRP might play the more dominant role in the pathophysiology of chronic hyperten-
sion. In line with this interpretation it has been shown that CGRP plasma levels are lower in
patients with essential hypertension and that plasma CGRP concentrations coincide with the
nocturnal drop in systemic blood pressure [33]. However, this finding is in contrast to other
studies reporting either unchanged [34] or even increased [35] CGRP plasma levels in hyper-
tensive patients. These both latter findings could eventually be explained by impaired receptor
function, which would fit to our observation of a reduced Calclr expression in hypertensive wt
mice. In patients with phaeochromocytom the reduced blood pressure and CGRP plasma con-
centrations observed after adrenalectomy, however, indicate that CGRP secretion might be a
compensatory mechanism to counteract hypertension [35]. Also in rats subjected to 2K1C sur-
gery hypertension was associated with an elevated CGRP plasma level suggesting a compensa-
tory role of this peptide in chronic hypertension [16]. Conversely, in phenol-induced
hypertension the reduction of circulation CGRP contributes significantly to the elevated blood
pressure [17]. Accordingly, in our experiments we found that CLR-tg mice developed slightly
less severe hypertension 10 weeks after 1K1C surgery (cf. Fig 3B).
A previous study reported that overexpression of RAMP-1 augments cerebrovascular re-
sponses to CGRP and protects from angiotensin II-induced vascular dysfunction [36]. The au-
thors conclude that CGRP-dependent cerebrovascular reactivity is RAMP-1-limited and, thus,
not critically dependent on the Calclr expression. This is in accordance with our findings be-
cause the hypertension-induced drop of Calclr expression in wt mice was not associated with a
comparable drop in AM or CGRP binding sites in the brain. The best explanation for this puta-
tive discrepancy is effective recycling of the Calclr. However, this is a difficult issue as the fate
of the Calclr (recycling vs. degradation) after internalization depends on the receptor stimula-
tion pattern (intermittent vs. sustained), fine-tuning of the expression of hepatocyte growth
factor-regulated tyrosine kinase substrate (HRS) [37] and maybe other (even unknown) factors
that could not be assessed in the present study. On the other hand, our data suggest that cere-
brovascular reactivity might be also Calclr-limited as CLR-tg mice have during normotension
as well as during chronic hypertension more CGRP binding sites in their brains. Of note,
RAMP-1 expression was about 3.5-times higher compared to RAMP-2 expression in the nor-
motensive state in both mouse lines and, more importantly, increased to a 6.6-times higher
RAMP-1 expression over that of RAMP-2 due to a significant hypertension-induced drop in
RAMP-2 expression. The latter is in accordance with a previous study on rats showing that
RAMP-2 is down regulated upon short (within 6h) increases of blood pressure [32]. Here we
show that this holds also for chronic hypertension and is most likely the primary cause for the
increase in CGRP binding sites as long as enough Calclr is present as it is the case in CLR-tg
mice but also in tendency in wt mice. This is an important notion because it demonstrates that
naturally the hypertensive stimulus results in a strong reduction of RAMP-2 expression at an
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almost maintained RAMP-1 expression and therefore a shift of the cerebrovascular sensitivity
ratio between CGRP and AM to CGRP. Overexpression of RAMP-1 [36] however univocally
defines a higher abundance of the CGRP receptors on the cell surface and thus covers the natu-
ral hypertension-induced shift in the CGRP / AM sensitivity ratio of the cerebral vasculature
that we describe here for the first time.
In summary our results suggest that chronic hypertension represses expression of all recep-
tor components for CGRP as well as AM, however, the repression of RAMP-2 expression is
strongest. As RAMP-2 expression is generally much lower than that of RAMP-1 the cerebrova-
scluar reactivity regarding CGRP and AM appears to rest mainly on CGRP and especially dur-
ing chronic hypertension because this condition even more increases the expression ration of
RAMP-1/RAMP2. Moreover chronic hypertension induces Acta2 [26] that is part of the con-
tractile apparatus in smooth muscle cells. In this setting the vasoreactivity appears to be pre-
served as long as the CGRP receptors are upregulated. Thus, CGRP receptors play a significant
role in maintenance of cerebrovascular reactivity during chronic hypertension, which should
be kept in mind when treating hypertensive patients with CGRP antagonists as suggested e.g.
for migraine [38].
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